Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5Thoracic 1Other neoplasm 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 882Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Stomach Neoplasms 513Esophageal Neoplasms 312Rectal Neoplasms 282Colonic Neoplasms 255Breast Neoplasms 204Neoplasms 201Liver Neoplasms 187Lung Neoplasms 175Carcinoma, Non-Small-Cell Lung 175Cholangiocarcinoma 152Ovarian Neoplasms 142Neoplasm Metastasis 137Gastrointestinal Neoplasms 134Esophageal Squamous Cell Carcinoma 130Melanoma 103Prostatic Neoplasms 99Biliary Tract Neoplasms 95Endometrial Neoplasms 83Uterine Cervical Neoplasms 79Head and Neck Neoplasms 72Squamous Cell Carcinoma of Head and Neck 69Carcinoma, Renal Cell 58Sarcoma 55Adenocarcinoma Of Esophagus 54Urinary Bladder Neoplasms 53Anus Neoplasms 52Triple Negative Breast Neoplasms 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Uterine Diseases × Gastrointestinal × Clear all
NCT06586957 2026-04-21

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NiKang Therapeutics, Inc.

Phase 1 Recruiting
150 enrolled
BreastGastrointestinalGynecologicThoracic

Neoplasm Metastasis, Ovarian Neoplasms, Stomach Neoplasms, Uterine Diseases, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡